These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 30191460)
1. CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes. Byeon JY; Kim YH; Lee CM; Kim SH; Chae WK; Jung EH; Choi CI; Jang CG; Lee SY; Bae JW; Lee YJ Arch Pharm Res; 2018 Sep; 41(9):921-930. PubMed ID: 30191460 [TBL] [Abstract][Full Text] [Related]
2. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Bradford LD Pharmacogenomics; 2002 Mar; 3(2):229-43. PubMed ID: 11972444 [TBL] [Abstract][Full Text] [Related]
4. Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans. Gaedigk A; Bradford LD; Marcucci KA; Leeder JS Clin Pharmacol Ther; 2002 Jul; 72(1):76-89. PubMed ID: 12152006 [TBL] [Abstract][Full Text] [Related]
5. Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population. Aynacioglu AS; Sachse C; Bozkurt A; Kortunay S; Nacak M; Schröder T; Kayaalp SO; Roots I; Brockmöller J Clin Pharmacol Ther; 1999 Aug; 66(2):185-92. PubMed ID: 10460072 [TBL] [Abstract][Full Text] [Related]
6. CYP2C9, CYP2C19, CYP2D6 and CYP3A5 polymorphisms in South-East and East Asian populations: A systematic review. Dorji PW; Tshering G; Na-Bangchang K J Clin Pharm Ther; 2019 Aug; 44(4):508-524. PubMed ID: 30980418 [TBL] [Abstract][Full Text] [Related]
7. Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population. Bathum L; Skjelbo E; Mutabingwa TK; Madsen H; Hørder M; Brøsen K Br J Clin Pharmacol; 1999 Sep; 48(3):395-401. PubMed ID: 10510152 [TBL] [Abstract][Full Text] [Related]
8. Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations. Yin SJ; Ni YB; Wang SM; Wang X; Lou YQ; Zhang GL J Clin Pharm Ther; 2012 Jun; 37(3):364-9. PubMed ID: 21913948 [TBL] [Abstract][Full Text] [Related]
9. Relationship of paroxetine disposition to metoprolol metabolic ratio and CYP2D6*10 genotype of Korean subjects. Yoon YR; Cha IJ; Shon JH; Kim KA; Cha YN; Jang IJ; Park CW; Shin SG; Flockhart DA; Shin JG Clin Pharmacol Ther; 2000 May; 67(5):567-76. PubMed ID: 10824636 [TBL] [Abstract][Full Text] [Related]
10. CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population. Scott SA; Edelmann L; Kornreich R; Erazo M; Desnick RJ Pharmacogenomics; 2007 Jul; 8(7):721-30. PubMed ID: 18240905 [TBL] [Abstract][Full Text] [Related]
11. Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians. Droll K; Bruce-Mensah K; Otton SV; Gaedigk A; Sellers EM; Tyndale RF Pharmacogenetics; 1998 Aug; 8(4):325-33. PubMed ID: 9731719 [TBL] [Abstract][Full Text] [Related]
12. Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in aborigines from western Australia. Griese EU; Ilett KF; Kitteringham NR; Eichelbaum M; Powell H; Spargo RM; LeSouef PN; Musk AW; Minchin RF Pharmacogenetics; 2001 Feb; 11(1):69-76. PubMed ID: 11207032 [TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam. Veiga MI; Asimus S; Ferreira PE; Martins JP; Cavaco I; Ribeiro V; Hai TN; Petzold MG; Björkman A; Ashton M; Gil JP Eur J Clin Pharmacol; 2009 Apr; 65(4):355-63. PubMed ID: 18979093 [TBL] [Abstract][Full Text] [Related]
14. Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment. Rau T; Heide R; Bergmann K; Wuttke H; Werner U; Feifel N; Eschenhagen T Pharmacogenetics; 2002 Aug; 12(6):465-72. PubMed ID: 12172215 [TBL] [Abstract][Full Text] [Related]
15. Discovery of novel functional variants and extensive evaluation of CYP2D6 genetic polymorphisms in Koreans. Lee SJ; Lee SS; Jung HJ; Kim HS; Park SJ; Yeo CW; Shin JG Drug Metab Dispos; 2009 Jul; 37(7):1464-70. PubMed ID: 19364831 [TBL] [Abstract][Full Text] [Related]
16. Debrisoquine and S-mephenytoin hydroxylation phenotypes and genotypes in a Korean population. Roh HK; Dahl ML; Johansson I; Ingelman-Sundberg M; Cha YN; Bertilsson L Pharmacogenetics; 1996 Oct; 6(5):441-7. PubMed ID: 8946476 [TBL] [Abstract][Full Text] [Related]
17. Influence of CYP2D6*10 on the pharmacokinetics of metoprolol in healthy Korean volunteers. Jin SK; Chung HJ; Chung MW; Kim JI; Kang JH; Woo SW; Bang S; Lee SH; Lee HJ; Roh J J Clin Pharm Ther; 2008 Oct; 33(5):567-73. PubMed ID: 18834373 [TBL] [Abstract][Full Text] [Related]
18. CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles. Leathart JB; London SJ; Steward A; Adams JD; Idle JR; Daly AK Pharmacogenetics; 1998 Dec; 8(6):529-41. PubMed ID: 9918137 [TBL] [Abstract][Full Text] [Related]
19. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population. Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309 [TBL] [Abstract][Full Text] [Related]
20. Relevance of the ancestry for the variability of the Drug-Metabolizing Enzymes CYP2C9, CYP2C19 and CYP2D6 polymorphisms in a multiethnic Costa Rican population. Céspedes-Garro C; Rodrigues-Soares F; Jiménez-Arce G; Naranjo MG; Tarazona-Santos E; Fariñas H; Barrantes R; Llerena A; Rev Biol Trop; 2016 Sep; 64(3):1067-76. PubMed ID: 29461783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]